Tezspire targets the airway epithelium, the primary source of inflammation. Credit: Emily Frost / Shutterstock. Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III ...
The company plans to push ahead with its Essential3 trial programme, despite indications it will fail to meet its endpoints. Credit: Shutterstock / R Photography Background. US-based Praxis Precision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback